Year :
2024
| Month :
February
| Volume :
18
| Issue :
2
| Page :
NJ01 - NJ02
Full Version
Sentinel Vessel Sign: A Shadow of the Subway Storm Setting into Strike Sight
Published: February 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/67055.19039
Rakesh Kumar Jha, Jaya Kaushik, Sunandan Bhatta
1. Assistant Professor, Department of Ophthalmology, Command Hospital, Lucknow, Uttar Pradesh, India.
2. Professor, Department of Ophthalmology, Command Hospital, Lucknow, Uttar Pradesh, India.
3. Assistant Professor, Department of Ophthalmology, Military Hospital, Agra, Uttar Pradesh, India.
Correspondence Address :
Dr. Rakesh Kumar Jha,
Assistant Professor, Department of Ophthalmology, Command Hospital, Cariappa Road, Lucknow Cantonment, Lucknow-226002, Uttar Pradesh, India.
E-mail: rkjhan2@y7mail.com
Abstract
A 56-year-old woman presented with a complaint of painless diminished vision in the right eye for nine months. Best-corrected visual acuity was 20/400 Oclulus Dexter (OD) and 20/20 Oculus Sinister (OS). Ophthalmological examination revealed a prominent solitary, tortuous, dilated episcleral sentinel vessel in the superonasal aspect of the right eye (white arrow, (Table/Fig 1)a). An undilated examination revealed a normal pupillary area (Table/Fig 1)b, but a dilated examination revealed a retrolental dome-shaped dark-brown mass in the superonasal quadrant protruding into the vitreous cavity (Table/Fig 1)c. Ultrasonography revealed a 9 mm acoustically-solid mass in maximum dimension with medium internal reflectivity (Table/Fig 1)d. A diagnosis of ciliochoroidal melanoma was made. A Computed Tomography (CT) scan of the head excluded extraocular extension (yellow arrow, (Table/Fig 1)e). Metastatic work-up, along with radiological imaging, excluded distant metastasis. Given the involvement of the ciliary body (which carries a worse prognosis), the involved eye was enucleated after due counseling with the patient. Subsequent histopathological examination, along with immunohistochemistry analysis of the lesion, revealed it to be a grade III-pT1-stage malignant melanoma with no local invasion. After enucleation, subsequent follow-up examinations for one year excluded any recurrence.
Keywords
Ciliary body melanoma, Melanoma, Ocular tumour
Discussion
Melanomas are usually asymptomatic and may remain clinically inapparent to the patient as well as to the clinician in the initial stage unless examined by widely dilating the pupil (1),(2), especially ciliary-body melanomas, which may attain a large size without any clinically evident involvement of the adnexal ocular structures and may silently metastasize to the liver and lungs extrasclerally through emissary veins (3).
Ciliary body melanomas constitute approximately 10% of uveal melanomas (4), with an average age of 55 to 62 years at the time of diagnosis (5). They have the worst prognosis, with a 10-year mortality rate reaching up to 30%-50% (5). Vital organ dysfunction resulting from vascular metastasis is the primary cause of mortality among these patients. Visual symptoms usually occur late, either when the tumour obscures the pupil or contacts the lens, and hence, can go undetected by the patient until it attains a large size. Additionally, compared to uveal melanomas, these tumours have vastly different unusual presenting signs, with case reports of orbital inflammation (6), angle-closure glaucoma (7), unilateral pigmentary glaucoma (8), spontaneous hyphema (9),(10), or the presence of metastases, sometimes to rare organs like the temporalis muscle at the time of diagnosis (11). However, in all these reported cases, the sentinel vessel was the most consistent external feature.
Sentinel vessels are disproportionately dilated and tortuous episcleral blood vessels, which are commonly associated with ciliary body melanomas compared with posteriorly located uveal melanomas. They provide clues for the presence of underlying asymptomatic occult ciliary body melanoma (12). Sometimes, sentinel vessels themselves may be occult, especially with small tumours in the early stages, visible only as trace conjunctival hyperemia. Marvasti AH et al., have illustrated scleral angiography for highlighting these occult hyperemic sectorial vessels for the detection of asymptomatic, suspicious ciliary body melanoma (13). Scleral angiography in their case was able to detect vascular abnormalities in focal regions of the sclera that otherwise appeared normal on the slit-lamp examination. The occult vessels demonstrated an early arterial phase that quickly included venous filling with pinpoint leaks that expanded gradually with time. In present case, authors made them apparent by blanching the other vessels with topical phenylephrine instillation.
Because this sign is constantly associated with ciliary body melanoma, its presence is additionally helpful in differentiating it from a multitude of its differential diagnoses, like tumours of the ciliary body pigmented epithelium (14) and non pigmented epithelium (15),(16), ciliochoroidal effusion, cysts, and several other tumours (17),(18), and pseudotumours (19),(20).
The episcleral sentinel vessel is a key clinical sign that points to a possible underlying malignancy and is helpful for its early detection to either salvage the eye or avoid life-threatening complications. It is important to be familiar with this sign, as small asymptomatic ciliary body melanoma may skip detection on screening ocular examination, and recognising it may provide a valuable clue for an in-depth clinical examination.
Reference
| 1. | Shields JA, Shields CL. Intraocular Tumours: An Atlas and Textbook. Lippincott Williams & Wilkins; 2015.
| 2. | Rosai J. Rosai and Ackerman’s Surgical Pathology.10th Edition. Elsevier Health Sciences.
| 3. | Costache M, Patrascu OM, Adrian D, Costache D, Sajin M, Ungureanu E, et al. Ciliary body melanoma- a particularly rare type of ocular tumour. Case report and general considerations. Maedica (Bucur). 2013;8(4):360-64.
| 4. | Singh AD. Essentials of Ophthalmic Oncology. Slack Incorporated; 2009:258.
[ CrossRef] [ PubMed] | 5. | Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973- 1997. Ophthalmology. 2003;110(5):956-61.
[ CrossRef] [ PubMed] | 6. | Chee YE, Mudumbai R, Saraf SS, Leveque T, Grieco VS, Mogensen MA, et al. Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma. Am. J. Ophthalmol case rep. 2021;23:101173.
[ CrossRef] [ PubMed] | 7. | Othman IS, Assem M, Zaki IM. Secondary glaucoma as initial manifestation of uveal melanoma. Saudi J Ophthalmol. 2013;27(3):203-08.
[ CrossRef] [ PubMed] | 8. | Ardjomand N, Eckhardt M, Langmann G, Faulborn J. Malignant melanoma of the ciliary body: A diagnostic problem. Ophthalmologe. 2001;98(4):406-08.
[ CrossRef] [ PubMed] | 9. | Abi-Ayad N, Grange JD, Watkin E. Ring melanoma revealed by spontaneous hyphema. J Fr Ophtalmol. 2007;30(7):729-32.
[ CrossRef] [ PubMed] | 10. | Pasarica MA, Curca PF, Dragosloveanu CDM, Tataru CI, Manole IR, Murgoi GE, et al. Underlying ciliary body uveal melanoma in a patient with chronic lymphocytic leukemia presenting for hyphema. Diagnostics (Basel). 2022;12(6):1312.
[ CrossRef] [ PubMed] | 11. | Oittinen HA, O’Shaughnessy M, Cullinane AB, Keohane C. Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle. J Clin Pathol. 2006;60:834-35.
[ CrossRef] [ PubMed] | 12. | Garmizo G. Sentinel episcleral vessels. A clue to the diagnosis of asymptomatic ciliary body melanoma. J Am Optom Assoc. 1984;55(8):599-600.
| 13. | Marvasti AH, Berry J, Sibug ME, Kim JW, Huang AS. Anterior segment scleral fluorescein angiography in the evaluation of ciliary body neoplasm: Two case reports. Case Rep Ophthalmol. 2016;7(1):30-38.
[ CrossRef] [ PubMed] | 14. | LoRusso FJ, Boniuk M, Font RL. Melanocytoma (magnocellular nevus) of the ciliary body: report of 10 cases and review of the literature. Ophthalmology. 2000;107(4):795-800.
[ CrossRef] [ PubMed] | 15. | Kaliki S, Shields CL, Eagle Jr RC, Vemuganti GK, Almeida A, Manjandavida FP, et al. Ciliary body medulloepithelioma: Analysis of 41 cases. Ophthalmology. 2013;120(12):2552-59.
[ CrossRef] [ PubMed] | 16. | Shields JA, Shields CL, Gündüz K, Eagle RC Jr. Adenoma of the ciliary body pigment epithelium: The 1998 Albert Ruedemann, Sr, memorial lecture, part 1. Arch Ophthalmol. 1999;117(5):592-97.
[ CrossRef] [ PubMed] | 17. | Shields JA, Shields CL, Eagle RC Jr, De Potter P. Observations on seven cases of intraocular leiomyoma. The 1993 Byron Demorest Lecture. Arch Ophthalmol. 1994;112(4):521-28.
[ CrossRef] [ PubMed] | 18. | Kuchle M, Holbach L, Schlötzer-Schrehardt U, Naumann GO. Schwannoma of the ciliary body treated by block excision. Br J Ophthalmol. 1994;78(5):397-400.
[ CrossRef] [ PubMed] | 19. | Brown HH, Brodsky MC, Hembree K, Mrak RE. Supraciliary hemangiopericytoma. Ophthalmology. 1991;98(3):378-82.
[ CrossRef] [ PubMed] | 20. | Finger PT, Narayana K, Iacob CE, Samson CM, Latkany P. Giant sarcoid tumour of the iris and ciliary body. Ocul Immunol Inflamm. 2007;15(2):121-25. [ CrossRef] [ PubMed] |
DOI: 10.7860/JCDR/2024/67055.19039
Date of Submission: Aug 17, 2023
Date of Peer Review: Nov 23, 2023
Date of Acceptance: Dec 14, 2023
Date of Publishing: Feb 01, 2024
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Aug 21, 2023
• Manual Googling: Dec 02, 2023
• iThenticate Software: Dec 12, 2023 (3%)
ETYMOLOGY: Author Origin
EMENDATIONS: 5
|